Discovery PK Now Offered at Charles River Massachusetts
January 31, 2011 - Our Preclinical Services facility at Charles River headquarters in Wilmington, MA, now provides rapid non-GLP pharmacokinetic (PK) screening studies to assist our sponsors in lead candidate selection from libraries of compounds. Our high-throughput bioavailability screening includes formulation, in vivo, small molecule bioanalytical and PK and toxicokinetic reporting services. Our experienced team is fully capable of perfoming discovery PK screening in rodent and nonrodent species.
We provide the following benefits to customers seeking non-GLP PK screening:
- Ability to meet aggressive timelines for outsourced PK programs
- Short lead time for study initiation (study starts within five to seven days of inquiry)
- Rapid turnaround times on in-life and bioanalytical studies (five to seven business days from receipt of test articles to submission of report, including PK calculations on bioanalytical data)
- Flexible scheduling to allow last-minute changes to study protocol
- Standardized, abbreviated protocols and reporting methods
For more information on our discovery PK screening services, click here or contact us at askcharlesriver@crl.com.